Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present two posters featuring real-world data from its ...
Morning Overview on MSN
Study suggests GLP-1 drugs may raise fracture and tendon injury risk
A peer-reviewed study of more than 46,000 older adults with type 2 diabetes found that patients who started GLP-1 receptor agonist drugs faced an 11 percent higher risk of fragility fractures compared ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果